Kenneth Fearon

Q: What Schools Are Affiliated With Kenneth Fearon

Kenneth Fearon is affiliated with the following schools: University of Edinburgh, University of Glasgow

Kenneth Fearon's AcademicInfluence.com Rankings

Kenneth Fearon

Philosophy

#4991

World Rank

#7686

Historical Rank

Logic

#2344

World Rank

#3320

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Kenneth Fearon Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Kenneth C. H. Fearon FRCSE FRCPSG was a 20th-century Scottish surgeon and cancer specialist. He was Professor of Surgical Oncology at the University of Edinburgh with a special interest in cachexia.

(See a Problem?)

Kenneth Fearon's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Definition and classification of cancer cachexia: an international consensus. (2011) (3613)
Enhanced Recovery After Surgery: A Review (2017) (1869)
ESPEN guidelines on nutrition in cancer patients. (2017) (1659)
Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". (2010) (1410)
Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. (2005) (1381)
Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations (2013) (1309)
The enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: a meta-analysis of randomized controlled trials. (2010) (1031)
Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) Group recommendations. (2009) (1010)
Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations. (2012) (950)
Cancer cachexia: mediators, signaling, and metabolic pathways. (2012) (884)
Sarcopenia with limited mobility: an international consensus. (2011) (848)
Cancer-associated cachexia (2018) (723)
Understanding the mechanisms and treatment options in cancer cachexia (2013) (692)
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. (2006) (672)
Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer (2009) (582)
Nutritional recommendations for the management of sarcopenia. (2010) (564)
Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial (2003) (554)
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations (2013) (547)
Cancer cachexia. (1999) (512)
The Impact of Enhanced Recovery Protocol Compliance on Elective Colorectal Cancer Resection: Results From an International Registry. (2015) (512)
A protocol is not enough to implement an enhanced recovery programme for colorectal resection (2007) (503)
Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. (2012) (498)
The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection (2005) (498)
The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer (1999) (466)
Diagnostic criteria for the classification of cancer-associated weight loss. (2015) (461)
Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice (2015) (444)
Characterization of a cancer cachectic factor (1996) (433)
Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids (2004) (418)
Cancer cachexia: developing multimodal therapy for a multidimensional problem. (2008) (403)
Guidelines for Perioperative Care for Pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations (2012) (400)
Cytokines, the Acute‐Phase Response, and Resting Energy Expenditure in Cachectic Patients with Pancreatic Cancer (1994) (399)
Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. (2016) (387)
The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. (1996) (343)
Acute‐phase protein response and survival duration of patients with pancreatic cancer (1995) (302)
Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. (2005) (298)
Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. (1995) (292)
Effect of Oral Eicosapentaenoic Acid on Weight Loss in Patients With Pancreatic Cancer (2000) (278)
Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 1: pathophysiological considerations (2015) (271)
Cachexia: prevalence and impact in medicine (2008) (270)
Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis (1996) (268)
Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. (2006) (267)
Patterns in current perioperative practice: survey of colorectal surgeons in five northern European countries (2005) (260)
Changes in nutritional status associated with unresectable pancreatic cancer. (1997) (241)
Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. (2012) (225)
Renal metabolism of amino acids: its role in interorgan amino acid exchange. (2004) (224)
Tumour necrosis factor in man: clinical and biological observations. (1987) (215)
Glutamine‐Supplemented Total Parenteral Nutrition Enhances T‐Lymphocyte Response in Surgical Patients Undergoing Colorectal Resection (1994) (210)
Initial experience with a multimodal enhanced recovery programme in patients undergoing liver resection (2008) (205)
Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. (2011) (203)
Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. (1997) (202)
A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer (2017) (198)
Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response. (1998) (187)
Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model--a study based on data from an international multicentre project (EPCRC-CSA). (2014) (187)
Influence of body composition profile on outcomes following colorectal cancer surgery (2016) (186)
Pathophysiology of cancer cachexia: much more than host-tumour interaction? (2007) (184)
Randomized clinical trial of the effect of postoperative intravenous fluid restriction on recovery after elective colorectal surgery (2006) (183)
Guidelines for perioperative care in elective rectal/pelvic surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations. (2012) (180)
Pancreatic Cancer as a Model: Inflammatory Mediators, Acute-phase Response, and Cancer Cachexia (1999) (175)
Muscle wasting in cancer. (2013) (172)
Determinants of outcome after colorectal resection within an enhanced recovery programme (2009) (171)
The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma. (2015) (164)
A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss (1999) (164)
Glutamine-supplemented total parenteral nutrition reduces blood mononuclear cell interleukin-8 release in severe acute pancreatitis. (1998) (158)
Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia (2010) (157)
Low Muscularity and Myosteatosis Is Related to the Host Systemic Inflammatory Response in Patients Undergoing Surgery for Colorectal Cancer (2016) (155)
Myopenia—a new universal term for muscle wasting (2011) (154)
Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. (1999) (153)
A comparison in five European Centres of case mix, clinical management and outcomes following either conventional or fast-track perioperative care in colorectal surgery. (2005) (153)
The mechanisms and treatment of weight loss in cancer (1992) (152)
A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. (1995) (151)
Effect of a Fish Oil-Enriched Nutritional Supplement on Metabolic Mediators in Patients With Pancreatic Cancer Cachexia (2001) (151)
Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss. (2005) (151)
Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. (1991) (151)
Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines. (1994) (150)
Consensus on cachexia definitions. (2010) (143)
Pain, depression, and fatigue as a symptom cluster in advanced cancer. (2011) (139)
The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: a systematic review. (2015) (136)
Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor (2000) (135)
Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency? (2005) (135)
The nutritional management of surgical patients: enhanced recovery after surgery (2003) (134)
Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals. (1987) (129)
Relationship between sedentary behaviour, physical activity, muscle quality and body composition in healthy older adults. (2012) (127)
Outcome of patients with abdominal sepsis treated in an intensive care unit (1995) (127)
Randomized controlled trial of the effect of early enteral nutrition on markers of the inflammatory response in predicted severe acute pancreatitis (2000) (127)
Gastric emptying of three liquid oral preoperative metabolic preconditioning regimens measured by magnetic resonance imaging in healthy adult volunteers: a randomised double-blind, crossover study. (2009) (126)
Prognostic Tools in Patients With Advanced Cancer: A Systematic Review. (2017) (126)
Cancer cachexia and fat-muscle physiology. (2011) (126)
Reduction of weight loss and tumour size in a cachexia model by a high fat diet. (1987) (125)
Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial (2018) (124)
Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. (1999) (123)
Intramyocellular lipid droplets increase with progression of cachexia in cancer patients (2011) (120)
Comparison of bio-impedance spectroscopy and multi-frequency bio-impedance analysis for the assessment of extracellular and total body water in surgical patients. (1995) (119)
Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. (1998) (116)
Influence of whole body protein turnover rate on resting energy expenditure in patients with cancer. (1988) (116)
Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. (2000) (116)
Evaluation of multi-frequency bio-impedance analysis for the assessment of extracellular and total body water in surgical patients. (1994) (114)
The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer. (2013) (111)
Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival. (2009) (110)
Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer. (2002) (109)
Cancer cachexia: influence of systemic ketosis on substrate levels and nitrogen metabolism. (1988) (105)
Randomized clinical trial of laxatives and oral nutritional supplements within an enhanced recovery after surgery protocol following liver resection (2010) (104)
Cancer cachexia and fatigue. (2006) (103)
Physical activity monitoring: a responsive and meaningful patient-centered outcome for surgery, chemotherapy, or radiotherapy? (2012) (102)
Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients. (1995) (100)
Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients (2011) (100)
Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer (1997) (99)
ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia (2017) (98)
Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. (1997) (97)
Prognosis in advanced lung cancer--A prospective study examining key clinicopathological factors. (2015) (96)
Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer. (1999) (91)
Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. (1995) (89)
Serum concentrations of myostatin and myostatin-interacting proteins do not differ between young and sarcopenic elderly men. (2011) (89)
A polymorphism of the interleukin-1 β gene influences survival in pancreatic cancer (2000) (87)
Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling (2017) (85)
Patient optimization for gastrointestinal cancer surgery (2013) (85)
Suppression of Skeletal Muscle Turnover in Cancer Cachexia: Evidence from the Transcriptome in Sequential Human Muscle Biopsies (2012) (85)
Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro. (1996) (84)
Efficacy of Intravenous Lidocaine for Postoperative Analgesia Following Laparoscopic Surgery: A Meta-Analysis (2015) (83)
Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy. (2007) (83)
Acute‐phase protein response, survival and tumour recurrence in patients with colorectal cancer (2001) (83)
Non-steroidal anti-inflammatory treatment in cancer cachexia: A systematic literature review (2013) (82)
Patterns and Clinical Outcomes Associated with Routine Intravenous Sodium and Fluid Administration after Colorectal Resection (2004) (82)
Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia. (2005) (79)
Body composition in cancer cachexia. (1990) (79)
Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis (1996) (79)
Cachexia in pancreatic cancer: new treatment options and measures of success. (2010) (78)
Sexual dimorphism modulates the impact of cancer cachexia on lower limb muscle mass and function. (2012) (76)
Psychosocial effects of cancer cachexia: a systematic literature search and qualitative analysis. (2013) (76)
Cachexia, survival and the acute phase response (2008) (76)
Evolving classification systems for cancer cachexia: ready for clinical practice? (2010) (75)
Early Stress Protein Gene Expression in a Human Model of Ischemic Preconditioning (2004) (73)
Evaluation of Novel Local Anesthetic Wound Infiltration Techniques for Postoperative Pain Following Colorectal Resection Surgery: A Meta-analysis (2014) (73)
Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients. (2007) (72)
Clinical Classification of Cancer Cachexia: Phenotypic Correlates in Human Skeletal Muscle (2014) (71)
Supplemental perioperative fluid administration increases tissue oxygen pressure. (2003) (71)
Peripheral blood cells from weight-losing cancer patients control the hepatic acute phase response by a primarily interleukin-6 dependent mechanism. (1999) (71)
Proinflammatory mediator activity, endogenous antagonists and the systemic inflammatory response in intra‐abdominal sepsis (1998) (66)
Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients (2015) (66)
The anti-catabolic effects of n-3 fatty acids. (1999) (65)
Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy (2014) (65)
Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. (2001) (63)
Effect of glutamine on immune function in the surgical patient. (1996) (62)
Patterns in current anaesthesiological peri‐operative practice for colonic resections: a survey in five northern‐European countries (2006) (61)
A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients. (1997) (61)
Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia (2001) (61)
Host Cytokine Genotype is Related to Adverse Prognosis and Systemic Inflammation in Gastro-Oesophageal Cancer (2007) (60)
Risk factors, complications and survival after upper abdominal surgery: a prospective cohort study (2015) (60)
Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility study (2010) (59)
Habitual Myofibrillar Protein Synthesis Is Normal in Patients with Upper GI Cancer Cachexia (2014) (59)
Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients. (1998) (57)
Clinical prognostic scoring system to aid decision‐making in gastro‐oesophageal cancer (2007) (57)
The Adaptive Response of the Reticuloendothelial System to Major Liver Resection in Humans (2006) (57)
Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2α may signal skeletal muscle atrophy in weight-losing cancer patients (2007) (55)
Relationship between weight loss, reduction of body cell mass and inflammatory response in patients with cancer (1994) (54)
Interleukin-4 and interleukin-10 increase endotoxin-stimulated human umbilical vein endothelial cell interleukin-8 release. (1995) (54)
Is There a Human Homologue to the Murine Proteolysis-Inducing Factor? (2007) (53)
Should cancer patients with incurable disease receive parenteral or enteral nutritional support? (1998) (53)
Cancer cachexia is associated with the IL10 -1082 gene promoter polymorphism in patients with gastroesophageal malignancy. (2009) (52)
Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients (2015) (51)
Leptin and its relation to weight loss, ob gene expression and the acute‐phase response in surgical patients (2001) (51)
Cellular Mechanisms Underlying the Protective Effects of Preoperative Feeding: A Randomized Study Investigating Muscle and Liver Glycogen Content, Mitochondrial Function, Gene and Protein Expression (2010) (49)
Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. (1997) (49)
Body composition measurement using computed tomography: Does the phase of the scan matter? (2017) (49)
Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic review (2011) (49)
New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss (2016) (48)
A novel oral tracer procedure for measurement of habitual myofibrillar protein synthesis. (2013) (48)
Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer (2011) (46)
The Sir David Cuthbertson Medal Lecture 1991 (1992) (46)
Cancer pain and its relationship to systemic inflammation: An exploratory study (2011) (46)
Alterations in the in vitro and in vivo regulation of muscle regeneration in healthy ageing and the influence of sarcopenia (2017) (46)
Nutritional Support and Oral Intake after Gastric Resection in Five Northern European Countries (2006) (44)
The effects of fasting and refeeding with a 'metabolic preconditioning' drink on substrate reserves and mononuclear cell mitochondrial function. (2010) (44)
Eicosanoid-dependent cancer cachexia and wasting (2002) (43)
GC/MS analysis of [2H5]phenylalanine at very low enrichment: measurement of protein synthesis in health and disease (1995) (43)
The 2011 ESPEN Arvid Wretlind lecture: cancer cachexia: the potential impact of translational research on patient-focused outcomes. (2012) (42)
An open-label phase I/II dose escalation study of the treatment of pancreatic cancer using lithium gammalinolenate. (1996) (42)
Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer (2010) (42)
The response of leptin, interleukin-6 and fat oxidation to feeding in weight-losing patients with pancreatic cancer (2004) (42)
Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients. (2004) (42)
"How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer. (2019) (41)
Patient-focused endpoints in advanced cancer: criterion-based validation of accelerometer-based activity monitoring. (2011) (41)
Modulation of human hepatocyte acute phase protein production in vitro by n-3 and n-6 polyunsaturated fatty acids. (1997) (41)
Practical multimodal care for cancer cachexia (2016) (40)
The cancer cachexia syndrome. (2001) (40)
Disordered Metabolic Response with Cancer and Its Management (2000) (40)
Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy (2006) (40)
Comprehensive proteome analysis of human skeletal muscle in cachexia and sarcopenia: a pilot study (2017) (38)
Magnetic resonance imaging with k-means clustering objectively measures whole muscle volume compartments in sarcopenia/cancer cachexia. (2011) (38)
Proinflammatory cytokines, nutritional support, and the cachexia syndrome (1998) (37)
P-selectin genotype is associated with the development of cancer cachexia (2012) (36)
Effect of megestrol acetate on weight loss, body composition and blood screen of gastrointestinal cancer patients. (1994) (35)
Tissue loss during severe wasting in lung cancer patients (1987) (34)
Loss of oxidative defense and potential blockade of satellite cell maturation in the skeletal muscle of patients with cancer but not in the healthy elderly (2016) (32)
Functional recovery is considered the most important target: a survey of dedicated professionals (2014) (32)
Prediction of 90 Day and Overall Survival after Chemoradiotherapy for Lung Cancer: Role of Performance Status and Body Composition. (2017) (32)
Dermcidin expression confers a survival advantage in prostate cancer cells subjected to oxidative stress or hypoxia (2007) (31)
Laparotomy for abdominal sepsis in the critically ill (1996) (31)
Serum parathyroid hormone‐related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma (2005) (31)
Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell lines (2008) (30)
Protein synthesis in cancer patients with inflammatory response: investigations with [15N]glycine. (1994) (30)
Endothelial-derived selectins in the development of organ dysfunction in acute pancreatitis (2001) (30)
Eicosapentaenoic acid perturbs signalling via the NFkappaB transcriptional pathway in pancreatic tumour cells. (2003) (29)
Failure of systemic ketosis to control cachexia and the growth rate of the Walker 256 carcinosarcoma in rats. (1985) (28)
The scientific rationale for optimizing nutritional support in cancer (2007) (28)
A randomized cross-over study of the metabolic and hormonal responses following two preoperative conditioning drinks. (2011) (27)
The dermcidin gene in cancer: role in cachexia, carcinogenesis and tumour cell survival (2008) (27)
The molecular mechanisms of skeletal muscle wasting: implications for therapy. (2006) (27)
Omics/systems biology and cancer cachexia. (2016) (27)
Eicosapentaenoic acid modulates the immune response but has no effect on a mimic of antigen-specific responses. (2005) (27)
Proteomic analysis of urinary upper gastrointestinal cancer markers (2011) (26)
Bioelectrical impedance analysis in the measurement of the body composition of surgical patients (1992) (26)
Enhanced Recovery After Surgery Interactive Audit System: 10 Years' Experience with an International Web-Based Clinical and Research Perioperative Care Database (2019) (26)
Preoperative conditioning with oral carbohydrate loading and oral nutritional supplements can be combined with mechanical bowel preparation prior to elective colorectal resection (2008) (25)
Mass spectrometric detection of candidate protein biomarkers of cancer cachexia in human urine. (2010) (25)
De-repression of heat shock transcription factor-1 in interleukin-6- treated hepatocytes is mediated by downregulation of glycogen synthase kinase 3beta and MAPK/ERK-1. (2007) (25)
Proximal and distal measurements of extracellular and total body water by multi-frequency bio-impedance analysis in surgical patients. (1998) (25)
Increased Skeletal Muscle 11βHSD1 mRNA Is Associated with Lower Muscle Strength in Ageing (2013) (24)
The enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: a metaanalysis of randomised controlled trials (2010) (23)
Reduction of the growth rate of the Walker 256 tumor in rats by rhodamine 6G together with hypoglycemia. (1987) (23)
An energy and protein dense, high n-3 fatty acid oral supplement promotes weight gain in cancer cachexia (2001) (23)
Biomarkers for cancer cachexia: is there also a genetic component to cachexia? (2008) (23)
Clofazimine alters the energy metabolism and inhibits the growth rate of a human lung‐cancer cell line in vitro and in vivo (1994) (23)
Food at will after pancreaticoduodenectomies. Re. "Perioperative nutritional support of patients undergoing pancreatic surgery in the age of ERAS". (2015) (22)
Simultaneous measurement of albumin and fibrinogen synthetic rates in normal fasted subjects. (1996) (22)
Effect of major liver resection on hepatic ureagenesis in humans. (2007) (22)
Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies (2014) (22)
Cytokine gene polymorphisms and susceptibility to cachexia (2010) (21)
Cancer cachexia. (2002) (21)
mRNA profiling of the cancer degradome in oesophago–gastric adenocarcinoma (2012) (21)
The energy balance in cancer cachexia revisited (2014) (21)
The Anorexia-Cachexia Syndrome (2009) (20)
Frequency of the mitochondrial DNA 4977bp deletion in oesophageal mucosa during the progression of Barrett's oesophagus. (2009) (20)
Health professionals' attitudes toward the detection and management of cancer-related anorexia-cachexia syndrome, and a proposal for standardized assessment. (2015) (20)
Interferon-γ polymorphisms correlate with duration of survival in pancreatic cancer (2004) (19)
The anti-cachectic effect of fatty acids (1998) (19)
Pancreaticoduodenectomy: ERAS recommendations. (2013) (19)
Functional body composition and related aspects in research on obesity and cachexia: report on the 12th Stock Conference held on 6 and 7 September 2013 in Hamburg, Germany (2014) (19)
Polyunsaturated fatty acids in the treatment of weight-losing patients with pancreatic cancer. (1994) (16)
Effect of interleukin-2 on peripheral blood mononuclear cell cytokine production and the hepatic acute phase protein response. (2002) (16)
Energy expenditure and protein synthesis rates in an animal model of cancer cachexia. (1991) (16)
Biomarkers for cancer cachexia: is there also a genetic component to cachexia? (2008) (15)
Is tissue cross-talk important in cancer cachexia? (2012) (15)
A randomised, open-label trial of a Multimodal Intervention (Exercise, Nutrition and Anti-inflammatory Medication) plus standard care versus standard care alone to prevent / attenuate cachexia in advanced cancer patients undergoing chemotherapy. (2015) (15)
Is there a genetic cause of appetite loss?—an explorative study in 1,853 cancer patients (2012) (15)
Anorexia, cachexia and nutrition (2008) (15)
Skeletal Muscle Changes After Elective Colorectal Cancer Resection: A Longitudinal Study (2016) (15)
Modulation of the cytokine and acute‐phase response to major surgery by recombinant interleukin 2 (1995) (14)
Randomized open‐label phase II study comparing oxycodone–naloxone with oxycodone in early return of gastrointestinal function after laparoscopic colorectal surgery (2017) (14)
Proteomic identification of potential cancer markers in human urine using subtractive analysis. (2016) (14)
The Human Urinary Proteome Fingerprint Database UPdb (2013) (14)
1483O_PRANAMORELIN FOR THE TREATMENT OF CANCER ANOREXIA-CACHEXIA IN NSCLC: RESULTS FROM THE PHASE 3 STUDIES ROMANA 1 AND 2 (2014) (14)
Interferon-gamma polymorphisms correlate with duration of survival in pancreatic cancer. (2004) (13)
Health-Related Quality of Life, Cachexia and Overall Survival After Major Upper Abdominal Surgery: A Prospective Cohort Study (2017) (13)
Acute abdomen: peritonitis (2005) (13)
Endogenous production of IL-8 by human colorectal cancer cells and its regulation by cytokines. (2001) (13)
Cachexia: Treat wasting illness on multiple fronts (2016) (12)
Interleukin-6, neutrophilia and the acute phase protein response in colorectal cancer patients. (1994) (12)
Nutritional predictors of postoperative outcome in pancreatic cancer (Br J Surg 2011; 98: 268–274) (2011) (12)
Is there a genetic cause for cancer cachexia? – a clinical validation study in 1797 patients (2011) (11)
The relationship between muscle protein content and CT-derived muscle radio-density in patients with upper GI cancer. (2016) (11)
Programmed cell death 6 interacting protein (PDCD6IP) and Rabenosyn‐5 (ZFYVE20) are potential urinary biomarkers for upper gastrointestinal cancer (2015) (11)
Serum interleukin 6 (IL-6) - effect of surgery and under-nutrition. (1991) (10)
Nutritional pharmacology in the treatment of neoplastic disease. (1988) (10)
Diet and colorectal cancer risk: Baseline dietary knowledge of colorectal patients (2004) (9)
The physiological response to surgical trauma (2004) (9)
Nutritional support in cancer (2001) (9)
Identification of diagnostic upper gastrointestinal cancer tissue type-specific urinary biomarkers (2019) (9)
Phase III trials of anamorelin in patients with advanced non-small cell lung cancer (NSCLC) and cachexia (ROMANA 1 and 2) (2015) (9)
Effect of an energy and protein dense, high n-3 fatty acid oral supplement on tumor response in patients with cancer cachexia (2002) (9)
PROCEEDINGS OF THE PHYSIOLOGICAL SOCIETY (2011) (8)
Cross sectional imaging of truncal and quadriceps muscles relates to different functional outcomes in cancer (2019) (8)
Anamorelin for the Treatment of Cancer Anorexia-Cachexia in Advanced NSCLC Patients: Results From ROMANA 1, a Pivotal Phase 3 Study (2014) (8)
Can a simple proteomics urine test assist in the early diagnosis of early-stage cancer? (2011) (8)
Overview: Key Elements and the Impact of Enhanced Recovery Care (2012) (7)
Effect of interleukin-4 on pro-inflammatory cytokine production and the acute phase response in healthy individuals and in patients with cancer or multiple organ failure. (1998) (7)
Nutritional consequences of cancer in man. (1986) (7)
Audit of nutritional support provided to surgical patients by a nutrition team. (1993) (7)
n-3 Polyunsaturated Fatty Acids in the Treatment of Pancreatic Cancer Cachexia (1999) (7)
The ERAS® Society (2015) (6)
LSCluster, a large-scale sequence clustering and aligning software for use in partial identity mapping and splice-variant analysis. (2013) (6)
Febrile-range temperature but not heat shock augments the acute phase response to interleukin-6 in human hepatoma cells. (2006) (6)
Corrigendum to "Prognosis in advanced lung cancer - A prospective study examining key clinicopathological factors" [Lung Cancer 88 (2015) 304-309]. (2017) (6)
A safety extension study of anamorelin in advanced non-small cell lung cancer patients with cachexia: ROMANA 3. (2015) (6)
Selective androgen receptor modulators in cancer cachexia? (2013) (6)
Anamorelin in patients with advanced non-small cell lung cancer and cachexia: Results from the phase III studies ROMANA 1 and 2. (2015) (6)
The oncology wall: Could Ali Baba have got to the nutrition treasure without using the correct words? (2013) (6)
Reply: Expression of the proteolysis-inducing factor core-peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastrooesophageal malignancy (2007) (6)
Metabolic disturbance and sensitivity to endotoxin in patients with advanced cancer: relationship to lymphocyte reactivity, tumour necrosis factor (TNF) production and survival (1996) (6)
Fatty acids for treating pancreatic cancer (1994) (5)
Proteomic identification of potential markers of myosteatosis in human urine. (2018) (5)
Diseases Associated with Cachexia: Cancer (2005) (5)
Urinary diagnostic proteomic markers for dynapenia in cancer patients. (2018) (5)
Cancer Cachexia (1988) (5)
Outcome of patients with abdominal sepsis treated in an intensive care unit (1995) (4)
Diet and colorectal cancer risk. Impact of a nutrition education leaflet (2004) (4)
Estimation of body cell mass (BCM) in surgical patients by bioelectrical impedance analysis (BIA) compared with total body potassium (TBK) measurement (1990) (3)
Development of a computer-administered mobility questionnaire (2011) (3)
Comparison of bieimpedance spectroscopy and mu It if requency biei m pedance analysis for the assessment of extracellular and total body water in surgical patients (2012) (3)
Diet and colorectal cancer risk: Evaluation of a nutrition education leaflet (2005) (3)
P.44 A fish oil-enriched nutritional supplement modulateschanges in the acute phase protein response in weight-losing pancreatic cancer patients (1998) (3)
Effect of interleukin-4 on pro-inflammatory cytokine production and the acute phase response in healthy individuals and in patients with cancer or multiple organ failure (1998) (3)
A Critical Assessment of the Outcome Measures and Goals of Intervention in Cancer Cachexia (2006) (3)
Prevention of Cachexia in Cancer (2013) (3)
4th Cachexia Conference (2007) (3)
1603 ROMANA 3: A safety extension study of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with cachexia (2015) (2)
Anamorelin in cachectic patients with non-small cell lung cancer (NSCLC) and low BMI (< 20 kg/m2): A pooled efficacy data analysis of two phase 3 studies. (2016) (2)
Plasma arginine concentrations are decreased in gastrointestinal cancer (2003) (2)
Albumin synthetic rates, the acute-phase response and cytokines in pancreatic-cancer (1995) (2)
1606 Nutritional support in cancer - more formal recommendations are required (2015) (2)
Pilot Phase II Trial of Formoterol Fumarate Combined with Megestrol Acetate in Patients with Advanced Malignancy (2011) (2)
Report on consensus conference on colorectal cancer: Royal College of Surgeons of Edinburgh 1993. (1996) (2)
Nutritional Intervention With n-3 Polyunsaturated Fatty Acids in Advanced Pancreatic Cancer (1998) (2)
Reply, Letter to the Editor - The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma. (2016) (2)
Nutritional support in surgical patients (2007) (2)
Author’s reply to letter from Dr. Gatt and colleagues (2010) (2)
1611TiPA novel multimodal treatment strategy for cancer cachexia; rationale and motivation for the MENAC (Multimodal – Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial (2017) (2)
Albumin synthesis rates, cytokines and the acute phase response in pancreatic cancer (1994) (1)
Upper GI 03 (2009) (1)
Resting energy expenditure, the acute phase response and cytokines in weight-losing patients with pancreatic cancer (1993) (1)
PP071-MON PRE-OPERATIVE WEIGHT LOSS INFLUENCES RECOVERY FOLLOWING POTENTIALLY CURATIVE RESECTION IN PATIENTS WITH UPPER GASTROINTESTINAL CANCER (2011) (1)
Anamorelin for the treatment of cancer anorexia-cachexia: Baseline characteristics from three phase III clinical trials (the ROMANA program). (2014) (1)
PP090-SUN: Feasibility of Dietary Counseling to Attenuate Cachexia in Patients with Advanced Cancer (2014) (1)
SURGICAL RESECTION RELINQUISHES SUPPRESSION OF SKELETAL MUSCLE TURNOVER IN CANCER PATIENTS (2012) (1)
Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling (2017) (1)
Efficacy of anamorelin in cachectic patients with non-small cell lung cancer (NSCLC) and low BMI (< 20 kg/m2): Post-hoc analysis of two phase III studies. (2016) (1)
Results From Phase III Trials of Anamorelin in Advanced Non-Small Cell Lung Cancer Patients with Cachexia: ROMANA 1 and 2 (2015) (1)
The European Society for Clinical Nutrition and Metabolism – 30th ESPEN Congress (2008) (1)
Anamorelin in cachectic patients with non-small cell lung cancer (NSCLC) and acute phase protein reaction (APPR): Pooled analysis of two phase 3 trials (ROMANA 1 and ROMANA 2) (2016) (1)
Outcome of patients with abdominal sepsis in an intensive care unit (1995) (1)
Hand grip dynamometry does not correlate with anthropometric measures of nutritional status in survivors of prolonged critical illness (2000) (1)
Effect of High-Fat Enteral Nutrition on Hepatocyte Injury in Response to Hemorrhagic Shock in the Rat (2007) (1)
P.57 Arrest of weight loss in cachectic pancreatic cancer patients receiving fish oil supplementation (1995) (1)
P.53 The nutritional status of patients with unresectablecancer of the pancreas (1995) (1)
Skeletal muscle Akt in upper gastrointestinal cancer patients and its potential as a biomarker of cachexia (2012) (1)
OR45: Body Composition in Non-Small Cell Lung Cancer (Nsclc) Patients with Cachexia and Improved Anorexia-Cachexia Symptoms: Anamorelin Phase 3 Trials Pooled Analysis (2016) (1)
Functional Parameters of Nutrition (2006) (1)
Human cancer cachexia - pathway analysis and identification of novel biomarkers in skeletal muscle (2010) (1)
The effect of an eicosapentaenoic acid-enriched nutritional supplement in weight-losing patients with advanced pancreatic cancer (1998) (1)
Nutritional Support in the Perioperative Period (2005) (1)
Erratum to: Enhanced Recovery After Surgery Interactive Audit System: 10 Years' Experience with an International Web-Based Clinical and Research Perioperative Care Database (2019) (1)
Whole body protein turnover (WBPT) and the acute phase protein response (APPR) in relation to the survival of colon cancer patients (1990) (1)
EDS Society News (2006) (1)
Supportive and palliative nutritional care for cancer patients (pts) with malnutrition and cachexia – a survey of healthcare providers (HCPs) (2016) (1)
O041 INVESTIGATING THE SAFETY AND METABOLIC EFFECTS OF A NEW ‘METABOLIC PREOPERATIVE PRECONDITIONING’ DRINK IN PATIENTS UNDERGOING GASTROINTESTINAL SURGERY: A RANDOMISED PLACEBO CONTROLLED DOUBLE-BLIND STUDY (NCT00662376) (2009) (1)
OP046 BODY COMPOSITION ANALYSIS USING COMPUTED TOMOGRAPHY SHOWS LOSS OF MUSCLE AND ADIPOSE TISSUE DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH GASTRO-OESOPHAGEAL CANCER (2010) (1)
PP083-SUN CT DERIVED MEASURES OF MUSCLE MASS ARE ASSOCIATED WITH FUNCTIONAL ABILITY BUT NOT STRENGTH AND POWER IN PATIENTS WITH UPPER GI CANCER (2013) (1)
PT07.3: A Critical Assessment of CT as a Valid Means of Skeletal Muscle Analysis and Muscular Body Composition Analysis in Cancer Cachexia (2019) (1)
Intraoperative surgical considerations for enhanced recovery after elective colonic surgery (2007) (1)
Investigating the dynamic metabolic and hormonal responses following ingestion of two 'preoperative' conditioning drinks: a randomized double-blind crossover study (2010) (1)
Physical activity as an objective measure of functional recovery and quality of life following upper gastrointestinal cancer resection (2012) (1)
OR33: The Impact of the Choice of Software Package on Computed Tomography Calculation of Body Composition Variables (2016) (1)
Nutrition in Surgery and Trauma (2015) (1)
[Enhanced recovery after elective colorectal surgery: reply]. (2014) (1)
Nutritional Support in the Surgical Patient (2009) (0)
PP069-MON IMPACT OF CANCER-ASSOCIATED WEIGHT-LOSS ON LOWER LIMB MUSCLE MASS AND FUNCTION (2011) (0)
O.43 A fish oil-enriched nutritional supplementreverses weight-loss in patients with advanced pancreatic cancer (1998) (0)
Estimation of the mass and distribution of body water in surgical patients by bioelectrical impedance analysis (BIA) (1990) (0)
Impressum, Vol. 17, Supplement 3, 1990 (1990) (0)
MON-PP096: Changes in Plasma Levels of Omega-3 Pufas in Response to Supplementation with Omega-3 Pufa-Enriched Oral Nutritional Supplements in Advanced Cancer Patients (2015) (0)
Effect of flutamide on survival in patients with pancreatic cancer. Results are impressive. (1999) (0)
Lack of association between Glucocorticoid Receptor and 11beta‐HSD1 expression and muscle function in healthy older men and women (2011) (0)
Absence of correlation between serum CRP levels and mitochondrial D-loop DNA mutations in gastro-oesophageal adenocarcinoma. (2014) (0)
Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies (2014) (0)
TheSystemic InflammatoryResponseand ItsRelationship toPainand OtherSymptoms inAdvancedCancer (2013) (0)
by isolated human hepatocytes Interleukin-8 can mediate acute-phase protein production (2012) (0)
894: Muscle mass of the host and dendritic cell phenotype in patients with colorectal cancer (2014) (0)
10.3.2 Classification, clinical assessment, and treatment of the anorexia-cachexia syndrome (2009) (0)
Tumour necrosis factor gene polymorphism and disease severity in acute pancreatitis (1998) (0)
Article Type: Original article (2009) (0)
Nutritional Support in Cancer Topic 26 Module 26 . 3 Multimodal Therapy for Cancer Cachexia (2014) (0)
Dietary effect on blood pressure (2002) (0)
degradation in adult rat diaphragm muscle The effect of denervation on protein synthesis and (2015) (0)
PP050-SUN UPPER AND LOWER LIMB MUSCLE MASS IN PATIENTS UNDERGOING SURGERY FOR UPPER Gl CANCER (2011) (0)
1534PNUTRITIONAL SUPPORT IN CANCER-SURVEY RESULTS IDENTIFY A NEED FOR MORE EDUCATION. (2014) (0)
cohort study comparing validated (2019) (0)
University of Birmingham Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients (2017) (0)
Methods of nutritional support for cancer patients (1986) (0)
Comparison of multi-frequency bio-impedance analysis (MFBIA) and bio-impedance spectroscopy (BIS) for the estimation of total body water (TBW) and extracellular volume (ECV) in surgical patients (1994) (0)
Absence of correlation between serum CRP levels and mitochondrial D-loop DNA mutations in gastro-oesophageal adenocarcinoma (2012) (0)
Edinburgh Explorer The anti-cachectic effect of fatty acids (2018) (0)
Quantification and optimisation of muscle volume MR images (2008) (0)
Inhalt, Vol. 17, Supplement 3, 1990 (1990) (0)
Comprehensive proteome analysis of muscle composition and development in seniors (2017) (0)
Using technology to positively influence dietary knowledge in colorectal clinic patients. (2004) (0)
P150 MUSCLE VOLUME AND QUALITY IN WEIGHT-LOSING UPPER GASTROINTESTINAL CANCER PATIENTS (2008) (0)
PP048-SUN CAN BASELINE MUSCLE MASS BE PREDICTED IN WEIGHT STABLE PATIENTS WITH CANCER? (2011) (0)
NHS Lothian Research Day (2008) (0)
A randomised, open-label, phase II study comparing targinact vs. oxycodone in early return of gastrointestinal function after laparoscopic colorectal surgery. (2016) (0)
PP264 A RANDOMISED STUDY OF THE METABOLIC AND HORMONAL RESPONSES FOLLOWING TWO PREOPERATIVE CONDITIONING DRINKS (NCT00909701) (2010) (0)
The evolution and impact of national ERAS societies: lessons to learn from ERAS-UK. (2015) (0)
Endogenous anti-endotoxin core antibodies in abdominal sepsis (1994) (0)
Early Nutrition and Early Mobilization: Why They Are Important and How to Make It Happen (2015) (0)
PWE-309 Intravenous lidocaine infusions for abdominal surgery (2015) (0)
Ibuprofen reduces resting energy expenditure and C-reactive protein production in cachectic patients with pancreatic cancer (1994) (0)
2nd Hellenic Congress of the Hellenic Society for Digestive Surgery (2006) (0)
271 Genotyping – does it matter in clinical practice for pain and cachexia? (2009) (0)
Clinical Practice 01 (2009) (0)
Debate: Nutrition support vs metabolic manipulation in the cancer patient (2002) (0)
PP232 CELLULAR MECHANISMS UNDERLYING THE PROTECTIVE EFFECTS OF PREOPERATIVE CARBOHYDRATE LOADING: A RANDOMISED STUDY INVESTIGATING MITOCHONDRIAL FUNCTION, GENE AND PROTEIN EXPRESSION (NCT00662376) (2010) (0)
OR39: The Impact of Contrast-Enhanced Versus Non-Enhanced Imaging on Computed Tomography Calculation of Body Composition Variables (2016) (0)
Muscle depletion is related to the host systemic inflammatory response in patients treated surgically for colorectal cancer. 2015, 102 (Suppl7) 26: Br J Surg (2015) (0)
Sarcopenic muscle shows distinct sex differences at the transcriptional level (2011) (0)
P103 THE EFFECTS OF FASTING AND REFEEDING WITH A ‘METABOLIC PRECONDITIONING’ DRINK ON SUBSTRATE RESERVES AND MITOCHONDRIAL FUNCTION: POTENTIAL MECHANISMS BY WHICH PREOPERATIVE FEEDING IMPROVES INSULIN SENSITIVITY (2009) (0)
Beyond ERAS? (2014) (0)
Comprehensive proteome analysis of skeletal muscle in cachexia and age-related sarcopenia: a pilot comparison of in vivo and in vitro models a (2017) (0)
O038 MEASUREMENT OF GASTRIC EMPTYING TIME OF THREE ORAL LIQUID PREOPERATIVE METABOLIC CONDITIONING REGIMENS USING A 13C-ACETATE BREATH TEST AND MAGNETIC RESONANCE IMAGING: A RANDOMISED, DOUBLE-BLIND, CROSSOVER VALIDATION STUDY (2008) (0)
PP095-SUN COMPUTED TOMOGRAPHY AND BIOELECTRICAL IMPEDANCE: RELEVANCE FOR BODY COMPOSITION ASSESSMENT IN ONCOLOGY (2013) (0)
Whole body protein synthesis and breakdown are unchanged after major hepatectomy for malignancies in man (2003) (0)
Myostatin and myostatin-interacting proteins do not differ between young and sarcopenic men (2010) (0)
PP049-SUN LOSS OF FAT FREE MASS OCCURS DURING NEO-ADJUVANT CHEMOTHERAPY FOR UPPER Gl CANCER (2011) (0)
Lunchtime Posters (2015) (0)
Modulation of the cytokine and acute-phase response to major surgery by recombinant interleukin 2. (1995) (0)
Symptom clusters in advanced cancer: role of systemic inflammation (2009) (0)
Early results from instituting an enhanced recovery program after colorectal surgery at two different surgical institutions in the EU (2003) (0)
The effects of IL-1 and counter regulatory hormone infusion on energy metabolism in the rat. (1990) (0)
Prevalence and clinical features of cancer cachexia (2013) (0)
Edinburgh Research Explorer Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines (2018) (0)
Pharmacological and Multimodal Therapy for Cancer Cachexia (2006) (0)
274 Treatment of cachexia-a preventive or symptomatic approach? (2009) (0)
SUN-P086: Weight Loss and Survival in Advanced Cancer in Relation to Inadequate Energy Intake (2016) (0)
Enhanced Recovery: Principles (2011) (0)
P1.06-003 Anamorelin in Cachectic Patients with Advanced NSCLC, a Post-Hoc Pooled Efficacy Data Analysis of Two Phase 3 Trials: Topic: Advanced General (2017) (0)
O057 INTERLEUKIN-10 GENOTYPE IS INDEPENDENTLY ASSOCIATED WITH ACCELERATED WEIGHT LOSS IN PATIENTS WITH GASTRO-OESOPHAGEAL CANCER (2008) (0)
A P-selectin polymophism is associated with the development of cancer cachexia: Results of a candidate gene association study (2011) (0)
Interleukin 1 gene locus polymorphisms and disease severity in acute pancreatitis (1998) (0)
Feasibility study of dietary counselling to attenuate cachexia in patients with advanced cancer. (2014) (0)
P3.06-004 A Systematic Review of Outcome Reporting in Studies of Radical Radiotherapy and Chemoradiotherapy in Lung Cancer: Topic: Clinical Studies (2017) (0)
Response to letter by Drs Safer and Safer Manuscript # YCLNU-S-15-01128 (2016) (0)
Edinburgh Research Explorer Skeletal Muscle Changes After Elective Colorectal Cancer Resection (2018) (0)
Benefits and Limitations of Conventional Nutritional Support (CNS) for Cancer Patients (CP) (2006) (0)
Muscle function in cancer cachexia: Influence of systemic inflammation (2009) (0)
Hormonal and Nutritional Factors Contributing to Tumour Cachexia (1990) (0)
P163 A NOVEL APPROACH TO ASSESS BODY COMPOSITION CHANGE ASSOCIATED WITH PANCREATIC CANCER: USE OF DIAGNOSTIC CT SCANS (2008) (0)
Symptom Clusters: Pain, Fatigue, Mood and Function (2008) (0)
Pharmaco-Nutritional Supports for the Treatment of Cancer Cachexia (2006) (0)
P147 MYOSIN HEAVY CHAIN IN HUMAN MUSCLE WASTING AN EARLY BIOMARKER OF CANCER CACHEXIA (2008) (0)
Edinburgh Research Explorer Identification of diagnostic upper gastrointestinal cancer tissue typespecific urinary biomarkers (2019) (0)
Muscle quality is maintained in healthy old women: Influence of muscle volume optimization (2007) (0)
Measuring the liquid-phase gastric emptying rate of sip feeds (2007) (0)
HabitualMyo fi brillarProteinSynthesis IsNormal in Patients with Upper GI Cancer Cachexia (2015) (0)
Physical Activity: A Response and Meaningful Patient-centred Outcome Measure in Palliative Oncology? (2010) (0)
Abstracts of Communications (1992) (0)
OP026 REGIONAL DIFFERENCES IN SKELETAL MUSCLE PROTEIN FRACTIONAL SYNTHETIC RATE IN PATIENTS WITH UPPER GASTROINTESTINAL CANCER (2013) (0)
Authors' reply (2001) (0)

This paper list is powered by the following services:

Other Resources About Kenneth Fearon

en.wikipedia.org

What Schools Are Affiliated With Kenneth Fearon?

Kenneth Fearon is affiliated with the following schools:

Kenneth Fearon's Academic­Influence.com Rankings